Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Recs

0
Player Avatar tixlong (93.23) Submitted: 5/27/2009 5:10:48 PM : Outperform Start Price: $8.60 RIGL Score: -60.23

double dip

Report this Post Reply

Featured Broker Partners


Advertisement